# Gotistobart Long Term Extension (LTE) Study

> **NCT07659379** · PHASE3 · ENROLLING_BY_INVITATION · sponsor: **OncoC4, Inc.** · enrollment: 20 (estimated)

## Conditions studied

- Advanced Solid Tumor

## Interventions

- **DRUG:** Gotistobart

## Key facts

- **NCT ID:** NCT07659379
- **Lead sponsor:** OncoC4, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2026-07-28
- **Primary completion:** 2036-07-01
- **Final completion:** 2037-01-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07659379

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07659379, "Gotistobart Long Term Extension (LTE) Study". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07659379. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*